IL58087A - Veterinary method to impart immunomodulating,antiviral and antitumor activity with 9-hydroxyalkyl-purines,their amine salts and some new such salts with p-acetamidobenzoic acid - Google Patents

Veterinary method to impart immunomodulating,antiviral and antitumor activity with 9-hydroxyalkyl-purines,their amine salts and some new such salts with p-acetamidobenzoic acid

Info

Publication number
IL58087A
IL58087A IL58087A IL5808779A IL58087A IL 58087 A IL58087 A IL 58087A IL 58087 A IL58087 A IL 58087A IL 5808779 A IL5808779 A IL 5808779A IL 58087 A IL58087 A IL 58087A
Authority
IL
Israel
Prior art keywords
salts
antiviral
activity
immunomodulating
purines
Prior art date
Application number
IL58087A
Other languages
English (en)
Original Assignee
Newport Pharmaceuticals
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Pharmaceuticals, Sloan Kettering Inst Cancer filed Critical Newport Pharmaceuticals
Publication of IL58087A publication Critical patent/IL58087A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom
    • C07D473/38—Sulfur atom attached in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL58087A 1978-09-15 1979-08-22 Veterinary method to impart immunomodulating,antiviral and antitumor activity with 9-hydroxyalkyl-purines,their amine salts and some new such salts with p-acetamidobenzoic acid IL58087A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/942,802 US4221909A (en) 1978-09-15 1978-09-15 P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines

Publications (1)

Publication Number Publication Date
IL58087A true IL58087A (en) 1983-03-31

Family

ID=25478620

Family Applications (1)

Application Number Title Priority Date Filing Date
IL58087A IL58087A (en) 1978-09-15 1979-08-22 Veterinary method to impart immunomodulating,antiviral and antitumor activity with 9-hydroxyalkyl-purines,their amine salts and some new such salts with p-acetamidobenzoic acid

Country Status (27)

Country Link
US (1) US4221909A (ko)
EP (1) EP0009154B1 (ko)
JP (1) JPS5547683A (ko)
KR (1) KR840000552A (ko)
AT (1) ATE1949T1 (ko)
AU (1) AU527851B2 (ko)
CA (1) CA1122217A (ko)
CS (1) CS251060B2 (ko)
DD (1) DD146049A5 (ko)
DE (1) DE2964211D1 (ko)
DK (1) DK149857C (ko)
ES (1) ES484167A1 (ko)
FI (1) FI68234C (ko)
GR (1) GR74076B (ko)
HU (1) HU182544B (ko)
IE (1) IE48827B1 (ko)
IL (1) IL58087A (ko)
IN (1) IN153099B (ko)
MX (1) MX6521E (ko)
NO (1) NO152445C (ko)
NZ (1) NZ191483A (ko)
PH (1) PH16315A (ko)
PL (2) PL119685B1 (ko)
PT (1) PT70180A (ko)
RO (1) RO77565A (ko)
YU (1) YU41884B (ko)
ZA (1) ZA793973B (ko)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4340726A (en) * 1980-03-14 1982-07-20 Newport Pharmaceuticals International, Inc. Esters
US4451478A (en) * 1982-03-12 1984-05-29 Newport Pharmaceuticals International, Inc. Imidazole compounds
US5147636A (en) * 1982-11-09 1992-09-15 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives and interferons
US4849411A (en) * 1982-11-09 1989-07-18 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
HUT36464A (en) * 1983-05-24 1985-09-30 Newport Pharmaceuticals Process for producing erythro-4-amino-3-/2-hydroxy-3-alkyl/-imidazol-5-carboxamide
IT1215339B (it) * 1987-01-14 1990-02-08 Co Pharma Corp Srl Procedimento per la preparazione di 9-(idrossialchil)-ipoxantine
US5091432A (en) * 1990-03-28 1992-02-25 Glasky Alvin J 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
US5614504A (en) * 1990-08-01 1997-03-25 The University Of South Florida Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
AU709454B2 (en) 1994-07-25 1999-08-26 Alvin J. Glasky Carbon monoxide dependent guanylyl cyclase modifiers
WO1997028803A1 (en) * 1996-02-12 1997-08-14 Cypros Pharmaceutical Corporation Hydroxynonyladenine analogs with enhanced lipophilic and anti-ischemic traits
AU3786299A (en) 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
WO2002004452A2 (en) 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CA2540598C (en) * 2003-10-03 2013-09-24 3M Innovative Properties Company Pyrazolopyridines and analogs thereof
US7585850B2 (en) * 2004-02-10 2009-09-08 Adenobio N.V. Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3215696A (en) * 1965-11-02 Substituted adenines -and preparation thereof
BE755361A (fr) * 1969-08-28 1971-03-01 Newport Pharmaceuticals Derives de l'inosine
US3728450A (en) * 1969-08-28 1973-04-17 Newport Pharmaceuticals Inosine derivatives
US3857940A (en) * 1971-05-21 1974-12-31 Newport Pharmaceuticals Inosine derivatives
US3836656A (en) * 1972-02-07 1974-09-17 Sandoz Ag Substituted purines as hypolipidemics
US3862189A (en) * 1973-08-14 1975-01-21 Warner Lambert Co Aralkyl-substituted purines and pyrimidines as antianginal bronchodilator agents
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
YU96177A (en) * 1976-04-24 1982-08-31 Wuelfing Johann A Process for obtaining adenine derivatives

Also Published As

Publication number Publication date
PL119685B1 (en) 1982-01-30
CA1122217A (en) 1982-04-20
ES484167A1 (es) 1980-09-01
HU182544B (en) 1984-02-28
YU224579A (en) 1983-12-31
IN153099B (ko) 1984-06-02
DK385679A (da) 1980-03-16
US4221909A (en) 1980-09-09
PL218317A1 (ko) 1980-06-16
JPS5547683A (en) 1980-04-04
IE791753L (en) 1980-03-15
DD146049A5 (de) 1981-01-21
AU527851B2 (en) 1983-03-24
PH16315A (en) 1983-09-05
FI68234B (fi) 1985-04-30
DK149857C (da) 1987-03-02
MX6521E (es) 1985-06-27
YU41884B (en) 1988-02-29
NZ191483A (en) 1983-06-14
CS251060B2 (en) 1987-06-11
FI792849A (fi) 1980-03-16
NO152445C (no) 1985-10-02
DE2964211D1 (en) 1983-01-13
RO77565A (ro) 1981-11-04
NO152445B (no) 1985-06-24
IE48827B1 (en) 1985-05-29
FI68234C (fi) 1985-08-12
PT70180A (en) 1979-10-01
AU5055779A (en) 1980-03-20
EP0009154B1 (en) 1982-12-08
GR74076B (ko) 1984-06-06
EP0009154A1 (en) 1980-04-02
JPH031309B2 (ko) 1991-01-10
ATE1949T1 (de) 1982-12-15
KR840000552A (ko) 1984-02-25
NO792792L (no) 1980-03-18
ZA793973B (en) 1980-09-24
DK149857B (da) 1986-10-13
PL124515B1 (en) 1983-01-31

Similar Documents

Publication Publication Date Title
IL58087A (en) Veterinary method to impart immunomodulating,antiviral and antitumor activity with 9-hydroxyalkyl-purines,their amine salts and some new such salts with p-acetamidobenzoic acid
US4302465B1 (ko)
PT77410B (en) Process for the preparation of a fungicidal composition containing substituted 1-hydroxymethyltriazolyl derivatives
DE3372362D1 (en) Polyprenylcarboxylic acid amides and process for preparing the same
IL73257A0 (en) Quinoline derivatives,their preparation and their use for the protection of plants
ES8505806A1 (es) Procedimiento para preparar nuevas sales de alquil(mixto) sulfonio de n-fosfonome-tilglicina
GB2019843A (en) N-Alkenylmoranoline derivatives
ES8206434A1 (es) Procedimiento para la preparacion de composiciones de sales amonicas cuaternarias para el tratamiento de textiles
GB2266889B (en) Dialkylglycamine compounds, their preparation and use as surfactants
ES8106147A1 (es) Procedimiento para preparar un 1,2,4-triazol-3-tiol
GB2009158A (en) Thienylmalonic Acid and Diesters Thereof
GB2016002A (en) Amino derivatives of pyrazolo[1,5-A]S.triazine
GB1548278A (en) Preparation of pyrryl-acetonitriles
GB2022075A (en) Lactam-N-acetic acids and the preparation thereof
BG48857A1 (en) Derivatives of phenylethanol amine, method for their preparation and use thereof
JPS5788154A (en) Preparation of beta-aminoacrolein
ES8704175A1 (es) Un procedimiento para la preparacion de derivados de benzopirano (2,3-d) triazol.
JPS5634688A (en) Preparation of cephapirin
MD113C2 (ro) Procedeu de obţinere a fenilalchilaminelor sau ale sărurilor acestor compuşi
JPS5663906A (en) Chemical preparation for agriculture and industry